A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

BACKGROUND: There is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and obtain consent from eligible APS patients and to obtain 95...

Descripción completa

Detalles Bibliográficos
Autores principales: Legault, Kimberly, Blostein, Mark, Carrier, Marc, Khan, Susan, Schulman, Sam, Shivakumar, Sudeep, Wu, Cynthia, Crowther, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183116/
https://www.ncbi.nlm.nih.gov/pubmed/32346486
http://dx.doi.org/10.1186/s40814-020-00594-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183116/
https://www.ncbi.nlm.nih.gov/pubmed/32346486
http://dx.doi.org/10.1186/s40814-020-00594-1

Ejemplares similares